Hematologic Malignancies
📧 Sign up to get email alerts when something new happens for Hematologic Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT [Phase 1]
A Phase I study evaluating conditioning with clofarabine and high-dose busulfan before allogeneic peripheral blood stem cell transplantation…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation [Phase 2]
Phase 2 trial evaluating palifermin to reduce acute graft-versus-host disease in patients with hematologic malignancies undergoing allogenei…
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT) [NA]
A completed clinical trial evaluated granulocyte colony-stimulating factor (filgrastim) in the bone marrow transplant setting, with results …
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Phase II Trial of Pentostatin and Targeted Busulfan [Phase 2]
Phase II trial evaluating pentostatin with targeted busulfan in hematologic malignancies has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies [Phase 1, Phase 2]
Phase 1/2 trial update on HSV-TK gene-transduced donor lymphocytes for hematologic malignancies; the study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients
A completed observational study by Janssen Korea evaluated the response rate of itraconazole injection in immunocompromised patients with he…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant [Phase 1, Phase 2]
This clinical trial update summarizes completed Phase 1/2 results evaluating vorinostat to prevent graft-versus-host disease after reduced-i…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Adult Double Cord Blood Transplant Study [Phase 2]
Phase 2 clinical trial update for an adult double cord blood transplant study evaluating cord blood stem cell transplantation in hematologic…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies [Phase 2]
A Phase 2 trial evaluating conditioning with an Umbilical Cord Blood Transplant for hematologic malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating an unrelated cord blood transplant plus a haplo-identical, T-cell depleted stem cell transplant from a r…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated the experimental agent LLME for reducing the incidence and severity of graft-versus-host disease after…
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Mindfulness Meditation in Bone Marrow Transplantation [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial from Emory University evaluating mindfulness meditation for patients undergoing bone marrow transplanta…
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies [Phase 1]
A Phase 1 dose-escalation trial of AS703569 in hematologic malignancies was terminated.
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. [Phase 1]
A completed Phase 1 trial evaluating the safety and preliminary efficacy of Fate Therapeutics' ProHema modulated umbilical cord blood units …
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation [Phase 1, Phase 2]
Results from a Phase 1/2 study evaluating the combination of bortezomib with tacrolimus and methotrexate to prevent graft-versus-host diseas…
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy [Phase 2]
A Phase 2 trial comparing pegfilgrastim versus filgrastim for neutrophil recovery after high-dose chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor [Phase 1, Phase 2]
Completed Phase 1/2 dose-ranging trial evaluating a T-cell add-back product depleted of host alloreactive cells in patients receiving haploi…
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets [NA]
Completed clinical trial comparing neutropenic diets versus non-neutropenic diets in patients undergoing myeloablative allogeneic stem cell …
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy [Phase 3]
Phase 3 trial evaluating recombinant human keratinocyte growth factor (Palifermin) to reduce oral mucositis in patients with hematologic mal…
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Extracorporal Photopheresis Pilot Study [Phase 1, Phase 2]
This clinical trial update concerns a pilot extracorporeal photopheresis study conducted in Phase 1/Phase 2 for hematologic malignancies. Th…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
Phase 1/2 trial of suicide gene–modified donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies
A completed clinical trial evaluating multiplex PCR for detecting DNA in neutropenic patients with hematologic malignancies.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Intra-bone Cord Blood Transplantation in Patients With Haematological Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating intra-bone cord blood transplantation in patients with high-risk or advanced hematologic malignancies; c…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies [Phase 2]
Phase 2 clinical trial evaluating stem cell transplantation with T-cell add-back for hematologic malignancies and bone marrow transplant rej…
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine [Phase 1]
Phase I dose-escalation study of oral SB939 alone or with azacitidine has completed, assessing safety/dosing in solid tumors and hematologic…